Posted Nov. 28, 2012 at 5:24 a.m.

Premium Lock GSK, others rebel against European government drug cuts

Published: 2012-11-28 05:24:00
Updated: 2012-11-28 05:24:00

Print this blog post
Duke links genetics to hepatitis C treatment effectiveness Duke links genetics to hepatitis C treatment effectiveness Image 1 of 3 · Next Image…

GlaxoSmithKline and Boehringer Ingelheim GmbH are among drugmakers delaying introductions or partially withdrawing their products in some European markets as governments raise the bar on what they're willing to pay....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll